Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.07
-0.02-1.83%
Last update: Oct 2, 4:20 PM
$1.09
N/A
MaxCyte Inc (MXCT) Stock Price, Quote, News & History
MXCTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MaxCyte (NASDAQ:MXCT) through any online brokerage.
Other companies in MaxCyte’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Illumina Inc (NASDAQ:ILMN).
MaxCyte has a consensus price target of $7.75.
The stock price for MaxCyte (NASDAQ: MXCT) is $1.09 last updated October 2, 2026 at 4:20 PM EDT.
There are no upcoming dividends for MaxCyte.
MaxCyte does not have any upcoming earnings scheduled.
There is no upcoming split for MaxCyte.
MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
